Sale!

EP-2(T) 5mg-60mg

Price range: $49.00 through $189.00

EP-2(T) 5mg-60mg is a research-grade analytical reference standard for receptor binding, molecular pathway analysis, and in vitro assays. ≥99% pure (HPLC verified), sterile lyophilized powder.

Vials Discount
2 - 10 10%
11 - 20 20%
21 + 30%

Third-Party Tested

Verified purity and quality standards.

Fast U.S. Shipping

Reliable delivery from our U.S. base.

Secure & Trusted

Safe and secure shopping with trusted payment protection.

Tirzepatide Research Peptide Overview

Tirzepatide Research Peptide is a synthetic dual-incretin peptide analogue offered under the EP-2(T) research designation. Researchers use this material in controlled laboratory studies focused on GIP and GLP-1 receptor systems, ligand design, receptor selectivity, signaling, and peptide stability. The product gives scientists a defined reference material for questions that depend on careful assay design, documented controls, and reproducible analytical methods.

In addition, A dual-receptor ligand gives researchers a model for comparing activity across two related class B GPCR systems. Moreover, differences in affinity, cyclic AMP signaling, receptor trafficking, and concentration-response behavior can reveal how one engineered peptide engages distinct targets. This context helps laboratories choose measurable endpoints instead of relying on broad assumptions about what a research compound should do.

Researchers can examine the Tirzepatide Research Peptide with receptor-expressing cell lines, binding assays, cyclic AMP measurements, receptor internalization studies, chromatography, and mass spectrometry. For example, analytical work can confirm identity, monitor stability, and identify degradation products before scientists interpret a biological assay. As a result, laboratories can separate questions about material quality from questions about molecular response.

Moreover, researchers can compare this material with EP-1(S), EP-3(R), CG, and AOD-9604. These side-by-side studies can reveal differences in sequence, receptor class, molecular size, stability, transport, or signaling. However, related products should not be treated as interchangeable simply because they appear in the same broad research category.

The published literature may include cell studies, animal experiments, reviews, or human studies of pharmaceutical-grade material. Therefore, researchers should match each citation to its actual study design and population. Findings from one experimental setting do not automatically describe a separate research-grade product. Encompass Peptides supplies this material for controlled laboratory investigation and analytical work only.

Finally, laboratories should record concentration, assay conditions, controls, temperature, timing, matrix, and analytical method when they evaluate this compound. Clear documentation improves reproducibility and helps researchers interpret results within the limits of the experiment. The Tirzepatide Research Peptide page should remain focused on laboratory science rather than clinical or consumer-use claims.

Tirzepatide Research Peptide Applications

  • GIP receptor research
  • GLP-1 receptor research
  • Dual-receptor signaling analysis
  • Cyclic AMP assays
  • Receptor trafficking research
  • Peptide-stability profiling

Related Research Peptides

Researchers comparing EP-2(T) 5mg–60mg may also explore:

  • EP-1(S) — GLP-1 receptor research.
  • EP-3(R) — multi-receptor research.
  • CG — amylin-related research.
  • AOD-9604 — peptide-fragment research.

Published Tirzepatide Research

View Tirzepatide Research Study on PubMed

Research Use Statement

For In Vitro Research Use Only. Encompass Peptides designates this material exclusively for controlled laboratory investigation. Published references provide scientific and educational context only. They do not establish the safety, efficacy, identity, or suitability of this research material for human or veterinary use.